Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vasopressin V1 receptor (V1R) is a G-protein coupled receptor that mediates the effects of arginine vasopressin (AVP) on various tissues, including vascular smooth muscle, liver, and brain. Its activation leads to vasoconstriction, increased blood pressure, and modulation of baroreflex sensitivity. It is a key target for vasopressin analogs used in the treatment of hypotensive states like septic or hemorrhagic shock.
Agonists activate the receptor, increasing intracellular Ca²⁺ via the phosphatidylinositol-bisphosphate cascade. Antagonists block vasopressin binding and downstream signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasopressin V1 receptor (V1R).